Bracco Diagnostics' MultiHance Contrast Agent Earns Expanded Labeling for Pediatric MRI

By A Mystery Man Writer

Description

Bracco Diagnostics Inc. announced the labeling of its contrast agent MultiHance has obtained U.S. Food and Drug Administration (FDA) approval for an extension to include magnetic resonance imaging (MRI) of the central nervous system (CNS) in pediatric patients younger than 2 years of age (including term neonates). The agent may now be used in this patient population to visualize lesions with abnormal blood-brain barrier or abnormal vascularity of the brain, spine and associated tissues.
Bracco Diagnostics' MultiHance Contrast Agent Earns Expanded Labeling for  Pediatric MRI
MR Imaging of Neoplastic Central Nervous System Lesions: Review and Recommendations for Current Practice
Bracco Diagnostics' MultiHance Contrast Agent Earns Expanded Labeling for  Pediatric MRI
Contrast-enhanced Magnetic Resonance Imaging in Pediatric Patients: Review and Recommendations for Current Practice - Ravi Bhargava, Gabriele Hahn, Wolfgang Hirsch, Myung-Joon Kim, Hans-Joachim Mentzel, Øystein E. Olsen, Eira Stokland, Fabio Triulzi, Elida
Bracco Diagnostics' MultiHance Contrast Agent Earns Expanded Labeling for  Pediatric MRI
Contrast-enhanced Magnetic Resonance Imaging in Pediatric Patients: Review and Recommendations for Current Practice - Ravi Bhargava, Gabriele Hahn, Wolfgang Hirsch, Myung-Joon Kim, Hans-Joachim Mentzel, Øystein E. Olsen, Eira Stokland, Fabio Triulzi, Elida
Bracco Diagnostics' MultiHance Contrast Agent Earns Expanded Labeling for  Pediatric MRI
Perfusion MRI: The Five Most Frequently Asked Technical Questions
Bracco Diagnostics' MultiHance Contrast Agent Earns Expanded Labeling for  Pediatric MRI
Advanced MRI Methods for Assessment of Chronic Liver Disease
Bracco Diagnostics' MultiHance Contrast Agent Earns Expanded Labeling for  Pediatric MRI
Conference Abstracts: CMR2013 - 2014 - Contrast Media & Molecular Imaging - Wiley Online Library
Bracco Diagnostics' MultiHance Contrast Agent Earns Expanded Labeling for  Pediatric MRI
Contrast-enhanced Magnetic Resonance Imaging in Pediatric Patients: Review and Recommendations for Current Practice - Ravi Bhargava, Gabriele Hahn, Wolfgang Hirsch, Myung-Joon Kim, Hans-Joachim Mentzel, Øystein E. Olsen, Eira Stokland, Fabio Triulzi, Elida
Bracco Diagnostics' MultiHance Contrast Agent Earns Expanded Labeling for  Pediatric MRI
Imaging Technology News - Magnetic Resonance Imaging (MRI)
Bracco Diagnostics' MultiHance Contrast Agent Earns Expanded Labeling for  Pediatric MRI
Magnetic resonance lymphangiography: with or without contrast? - Abstract - Europe PMC
Bracco Diagnostics' MultiHance Contrast Agent Earns Expanded Labeling for  Pediatric MRI
Gadolinium What Is Gadolinium & What Is It Used for in MRIs?
Bracco Diagnostics' MultiHance Contrast Agent Earns Expanded Labeling for  Pediatric MRI
Pediatric magnetic resonance angiography: to contrast or not to contrast
Bracco Diagnostics' MultiHance Contrast Agent Earns Expanded Labeling for  Pediatric MRI
Magnetic Resonance Angiography of the Thoracic Vasculature: Technique and Applications - Ludwig - 2020 - Journal of Magnetic Resonance Imaging - Wiley Online Library
Bracco Diagnostics' MultiHance Contrast Agent Earns Expanded Labeling for  Pediatric MRI
MR Imaging of Neoplastic Central Nervous System Lesions: Review and Recommendations for Current Practice
Bracco Diagnostics' MultiHance Contrast Agent Earns Expanded Labeling for  Pediatric MRI
Contrast-enhanced Magnetic Resonance Imaging in Pediatric Patients: Review and Recommendations for Current Practice - Ravi Bhargava, Gabriele Hahn, Wolfgang Hirsch, Myung-Joon Kim, Hans-Joachim Mentzel, Øystein E. Olsen, Eira Stokland, Fabio Triulzi, Elida
Bracco Diagnostics' MultiHance Contrast Agent Earns Expanded Labeling for  Pediatric MRI
MR Imaging of Neoplastic Central Nervous System Lesions: Review and Recommendations for Current Practice
from per adult (price varies by group size)